Neoepitope-based Personalized Vaccine Approach in Patients With Newly Diagnosed Glioblastoma
Clinical trial NCT02510950 · TERMINATED
Trial details
- NCT number
- NCT02510950
- Sponsor
- Washington University School of Medicine
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2015-12-03
- Primary completion
- 2017-02-14
- Enrollment
- 1
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.